-+*Download pdf Questions Key take-home messages The issue and why it’s important PrEP is a highly effective medication taken to prevent HIV. PrEP consists of the use of antiretroviral drugs to lower the chance of HIV infection when taken by individuals at risk of acquiring (18, 19). PrEP reduces the risk of contracting HIV from […]
Delivery models of pharmacy-led HIV pre-exposure prophylaxis (PrEP) Read More »
-+*Dear OHTN Community, It is with great excitement that I am writing share some important news regarding our leadership at the Ontario HIV Treatment Network (OHTN). Effective December 2nd, Nadine Sookermany will join us as our new Chief Executive Officer. Coming directly from a significant leadership role as the Executive Director of Fife House, Nadine
OHTN announces Nadine Sookermany as new CEO Read More »
-+*Ontario HIV Treatment Network (OHTN) The OHTN is a non-profit funded by HIV and Hepatitis C Programs at the Ontario Ministry of Health. We’re a node of collaboration; our work brings together key partners from across the sector to improve the lives of all Ontarians living with and at risk of HIV. Ontario Advisory Committee
-+*The Board of Directors of the Ontario HIV Treatment Network (OHTN) is writing to advise that Jean Bacon, OHTN’s Executive Director, is planning to retire later this year. Jean leaves behind an incredible legacy. She has worked in the HIV sector since 1986, including more than 15 years at the OHTN, with the last seven
Message from the Board: Executive Director Jean Bacon announces retirement Read More »
-+*Download report as PDF The Ontario HIV Treatment Network is strongly committed to diversity, resilience and health equity. To mark the International Day Against Homophobia, Transphobia, and Biphobia, and in solidarity with the communities we work to support, we asked our Knowledge Synthesis and Data & Applied Science Impact teams to share their findings on
Evidence Report on homophobia, transphobia and biphobia for IDAHOBIT 2023 Read More »
-+*Download full report Version française HIV pre-exposure prophylaxis (PrEP) is the use of antiretroviral medication on an ongoing basis to reduce one’s risk of acquiring HIV infection. When taken consistently and correctly, PrEP is a highly effective HIV-risk reduction strategy and a critical part of comprehensive HIV prevention. To ensure that everyone who could benefit
HIV pre-exposure prophylaxis (PrEP) in Ontario, 2021 Read More »
-+*Télécharger le rapport complet English version La prophylaxie pré-exposition (PrEP) consiste à prendre des médicaments antirétroviraux sur une base continue afin de réduire le risque de contracter le VIH. Lorsqu’elle est prise régulièrement et correctement, la PrEP est une stratégie hautement efficace de réduction du risque d’infection et une composante centrale de la prévention globale
La prophylaxie pré-exposition (PrEP) contre le VIH en Ontario, 2021 Read More »
-+*Download PDF Visit HIVTestingOntario News Release 1. Overview The release of the updated HIV testing guidelines—Ontario Guidelines for Providers Offering HIV Testing—represents a progressive step forward in efforts to eliminate new HIV infections in Ontario. In 2019, the rate of first-time HIV diagnoses was the lowest it has been since 1985. Antiretroviral therapy (ART)—medication
HIV Testing Guidelines Media Backgrounder Read More »
-+*Download pdf Question Key take-home messages The issue and why it’s important Hepatitis C virus (HCV) is transmitted when the blood of an infected person comes into contact with the blood of an uninfected person (23). Approximately 25% of individuals spontaneously clear the virus after infection; however, the majority of individuals go on to develop
